article thumbnail

Women in Pharma® Editorial: Can Communication in a Multigenerational Environment Be Inclusive?

ISPE

Women in Pharma® Editorial: Can Communication in a Multigenerational Environment Be Inclusive? Trudy Patterson Mon, 07/03/2023 - 15:34 Insights July / August 2023 Women in Pharma® Editorial: Can Communication in a Multigenerational Environment Be Inclusive? 4 They also value face-to-face interactions.

article thumbnail

CDER’s Office of Compliance Kicks Off Annual Report Season with Rundown of 2023’s Major Public Health Enforcement Initiatives

The FDA Law Blog

OCs recent 2023 Annual Report—covering the fiscal year from October ’22 to September ’23—puts some meat on the bones of those issues and describes how OC touches almost every area of enforcement that CDER undertakes. Communication in this area included on-line videos, webinars, summits, conferences, and international outreach.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opportunities in 2023

PQA

PQA’s 2023 calendar is shaping up to be full of opportunities for members to engage in our work and advance the quality of medication use. We encourage you to share this blog series with colleagues as a springboard for engagement. You should be receiving Five For Friday in your inbox, but it is also posted on our blog.

article thumbnail

Conference Notebook: Reporting from FDLI’s 2023 Enforcement, Compliance, and Litigation Conference

The FDA Law Blog

We’ve blogged on VSDs previously here and here , as the application of the VSD for FDA-regulated industry has been vexing. He also noted that the VSD “does not supplant existing obligations to report to appropriate regulatory agencies, nor is it intended to alter those existing practices and channels of communication.”

FDA 52
article thumbnail

May 11, 2023: The End of the COVID-19 Pandemic Emergency’s DEA Telemedicine Exemption? “Not So Fast,” Say DEA and SAMHSA

The FDA Law Blog

Palmer — We blogged earlier this week here that DEA is reconsidering its proposed rules for telemedicine prescribing of controlled substances and buprenorphine. 30,038 (May 10, 2023). By Karla L. 802(54)(G) (which references CMS’s statutory definition of “practice of telemedicine”). 1307.41and 42 C.F.R.

article thumbnail

Science Summarised: NF2 and Sporadic Vestibular Schwannoma

NF2 BioSolutions

The previous blog posts in this series: Science Summarised: Potential New Drugs for Hearing Loss Science Summarised: All Things Meningioma This blog was written by NF2 BioSolutions PhD student Grace Gregory. Find the full open access paper here or read the blog below for a bite-sized version open to a non-scientific audience.

article thumbnail

Science Summarised: Potential New Drugs for Hearing Loss

NF2 BioSolutions

For some people, hearing loss is associated with communication difficulties, poor social interaction, unemployment, anxiety and depression. This blog has been created as a way to share stories, ideas, positivity and even sprinkle in some science. If you would like to add anything (anything at all!)